@WHO: Primary analysis of data from Phase III trials of the AstraZeneca/Oxford #COVID19 vaccine has so far shown that it offers protection against severe disease, hospitalisation & death. It is vital now to determine its effectiveness when it comes to preventing more severe illness. https://t.co/9ryuI4NaZO

http://twitter.com/WHO
via IFTTT